ascopubs.org

Capecitabine (Cap) combined with bevacizumab (Bev) with or without vinorelbine (Vin) in first-line metastatic breast cancer (MBC): First safety results from the randomized ...

Identification of pathogenic macrophages in breast cancer as markers of tumor aggressiveness. Background: In RIBBON-1, the combination of Bev with Cap as 1st-line therapy for MBC significantly ...
ascopubs.org

Capecitabine (Cap) monotherapy in anthracycline (A)/taxane (T)-pretreated MBC.

Effects of an mTOR inhibitor RAD001 on human breast cancer stem cells in vitro and in vivo. Cap vs sunitinib 244 vs 38 24.6 vs 15.3 4.2 vs 2.8 16.0 vs 11.0 Cap vs V-G 54 vs 60 14.6 vs 12.5 5.0 vs 3.7 ...